Your Location:
Home >
Browse articles >
Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway
Original Article | Updated:2021-08-23
    • Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway

    • Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway

    • Chinese Journal of Integrative Medicine   2020年26卷第5期 页码:345-352
    • DOI:10.1007/s11655-018-3024-0    

      中图分类号:
    • 纸质出版日期:2020-05-01

      网络出版日期:2019-01-09

      录用日期:2018-05-30

    Scan for full text

  • Liang WANG, Hui SHI, Jin-ling HUANG, 等. Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2020,26(5):345-352. DOI: 10.1007/s11655-018-3024-0.

    Liang WANG, Hui SHI, Jin-ling HUANG, et al. Linggui Zhugan Decoction (苓桂术甘汤) Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Rats by Suppressing TGF-β1/Smad Signaling Pathway[J]. Chinese Journal of Integrative Medicine, 2020,26(5):345-352. DOI: 10.1007/s11655-018-3024-0.

  •  
  •  
More>

0

浏览量

0

Downloads

4

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Lingbao Huxin Pill Alleviates Apoptosis and Inflammation at Infarct Border Zone through SIRT1-Mediated FOXO1 and NF-κB Pathways in Rat Model of Acute Myocardial Infarction
Qingxuan Jiangya Decoction (清眩降压汤) Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF-β1/Smad Pathway in Spontaneously Hypertensive Rats
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway

相关作者

暂无数据

相关机构

National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Peking University Traditional Chinese Medicine Clinical Medical School (Xiyuan Hospital)
Department of Graduate School, Beijing University of Chinese Medicine
Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine
Chen Keji Academic Thought Inheritance Studio, Fujian University of Traditional Chinese Medicine
0